NCT00670839View on ClinicalTrials.gov

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

February 28, 2013

Conditions
Hepatitis BHIV Infection
Interventions
BIOLOGICAL

GenHevac-B

1 intramuscular injection of Genhevac-B® 20μg on day zero, month 1,and month 6

BIOLOGICAL

GenHevac-B

2 intramuscular injections of Genhevac-B® 20μg on day zero, month 1,and month 6

Trial Locations (1)

67091 Cedex

Centre de Soins de l'Infection par le VIH NHC, Hôpitaux Universitaires Strasbourg, 1 place de l'hôpital, Strasbourg

Sponsors

Collaborators (1)

MCM Vaccines B.V.
All Listed Sponsors
collaborator

MCM Vaccines B.V.

INDUSTRY

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT00670839 - Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) | Biotech Hunter | Biotech Hunter